BiomX Inc.

Biomx Inc.

Biotechnology Healthcare Ness Ziona, Israel PHGE (ASE)

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. The company was founded in 2015 and is headquartered in Ness Ziona, Israel.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has BiomX Inc. had layoffs?
No layoff events have been recorded for BiomX Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does BiomX Inc. have?
BiomX Inc. has approximately 52 employees.
What industry is BiomX Inc. in?
BiomX Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is BiomX Inc. a publicly traded company?
Yes, BiomX Inc. is publicly traded under the ticker symbol PHGE on the ASE. The company has a market capitalization of approximately $0.00 billion.
Where is BiomX Inc. headquartered?
BiomX Inc. is headquartered in Ness Ziona, Israel at 22 Einstein Street, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.